Silmara Allegretti

Prof. Silmara Allegretti

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2014 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
JMJosue De Moraes
Josue De Moraes
RORosimeire N De Oliveira
Rosimeire N De Oliveira
JCJéssica P Costa
Jéssica P Costa
AJAntonio L G Junior
Antonio L G Junior
Damiao Pergentino de SousaDamiao Pergentino de Sousa
Damiao Pergentino de Sousa
PPPedro L S Pinto
Pedro L S Pinto
Schistosomiasis is a major endemic disease that affects hundreds of millions worldwide. Since the treatment and control of this parasitic disease rely on a single drug, praziquantel, it is imperative that new effective drugs are developed. Here, we report that phytol, a diterpene alcohol from chlorophyll widely used as a food additive and in medicinal fields, possesses promising antischistosomal properties in vitro and in a mouse model of schistosomiasis mansoni. In vitro, phytol reduced the motor activity of worms, caused their death and confocal laser scanning microscopy analysis showed extensive tegumental alterations in a concentration-dependent manner (50 to 100 µg/mL). Additionally, phytol at sublethal doses (25 µg/mL) reduced the number of Schistosoma mansoni eggs. In vivo, a single dose of phytol (40 mg/kg) administered orally to mice infected with adult S. mansoni resulted in total and female worm burden reductions of 51.2% and 70.3%, respectively. Moreover, phytol reduced the number of eggs in faeces (76.6%) and the frequency of immature eggs (oogram pattern) was significantly reduced. The oogram also showed increases in the proportion of dead eggs. Confocal microcopy studies revealed tegumental damage in adult S. mansoni recovered from mice, especially in female worms. The significant reduction in parasite burden by this chlorophyll molecule validates phytol as a promising drug and offers the potential of a new direction for chemotherapy of human schistosomiasis. Phytol is a common food additive and nonmutagenic, with satisfactory safety. Thus, phytol has potential as a safe and cost-effective addition to antischistosomal therapy. Schistosomiasis is an infectious parasitic disease caused by helminths from the genus Schistosoma, which affects hundreds of millions of people, mainly the poor. Despite schistosomiasis being one of the most prevalent and debilitating neglected tropical diseases, the treatment and control of this disease relies on a single drug, praziquantel. However, there is increasing concern about the development of drug resistance. For this reason, the search for new schistosomicidal agents is a priority. Here, we report that phytol, a molecule from chlorophyll widely used as a food additive and in medicinal fields, shows promising antischistosomal properties against adult Schistosoma mansoni in vitro and in laboratory studies with mice harbouring adult S. mansoni. Phytol is a common food additive and is nonmutagenic, with satisfactory safety. Thus, phytol has potential as a safe and cost-effective addition to antischistosomal therapy. Further studies are needed because our results might have public health relevance.

27 March 2015 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
MGMaria A Guimarães
Maria A Guimarães
RORosimeire N de Oliveira
Rosimeire N de Oliveira
LVLeiz M C Véras
Leiz M C Véras
DLDavid F Lima
David F Lima
YCYuri D M Campelo
Yuri D M Campelo
Jose Roberto LeiteJose Roberto Leite
Jose Roberto Leite
Schistosomiasis is a serious disease currently estimated to affect more that 207 million people worldwide. Due to the intensive use of praziquantel, there is increasing concern about the development of drug-resistant strains. Therefore, it is necessary to search for and investigate new potential schistosomicidal compounds. This work reports the in vivo effect of the alkaloid epiisopiloturine (EPI) against adults and juvenile worms of Schistosoma mansoni. EPI was first purified its thermal behavior and theoretical solubility parameters charaterised. In the experiment, mice were treated with EPI over the 21 days post-infection with the doses of 40 and 200 mg/kg, and 45 days post-infection with single doses of 40, 100 and 300 mg/kg. The treatment with EPI at 40 mg/kg was more effective in adult worms when compared with doses of 100 and 300 mg/kg. The treatment with 40 mg/kg in adult worms reduced parasite burden significantly, lead to reduction in hepatosplenomegaly, reduced the egg burden in faeces, and decreased granuloma diameter. Scanning electron microscopy revealed morphological changes to the parasite tegument after treatment, including the loss of important features. Additionally, the in vivo treatment against juvenile with 40 mg/kg showed a reduction of the total worm burden of 50.2%. Histopathological studies were performed on liver, spleen, lung, kidney and brain and EPI was shown to have a DL50 of 8000 mg/kg. Therefore EPI shows potential to be used in schistosomiasis treatment. This is the first time that schistosomicidal in vivo activity of EPI has been reported. Schistosomiasis, a disease caused by worms from the genus Schistosoma, is one of the most widespread neglected tropical diseases in the world. Due to the intensive use of praziquantel, some reports of drug resistance have emerged. Thus it is important to search for new chemotherapeutic agents for the treatment disease. This research showed that epiisopiloturine, an imidazole alkaloid extracted from the leaves of Pilocarpus microphylus, has activity against S. mansoni in vivo. This material is produced as a by-product of an existing commercial process, and thus can be produced in large quantities at relatively low cost. The low toxicity and high drug tolerance in mammals shows the potential of epiisopiloturine as a new candidate schistosomicidal compound.

1 October 2012 in Experimental Parasitology
Verified
Journal Article
Closed access
RORosimeire Nunes de Oliveira
Rosimeire Nunes de Oliveira
VRVera Lúcia Garcia Rehder
Vera Lúcia Garcia Rehder
AOAdriana S. Santos Oliveira
Adriana S. Santos Oliveira
ÍJÍlio Montanari Júnior
Ílio Montanari Júnior
JCJoão Ernesto de Carvalho
João Ernesto de Carvalho
SASilmara Allegretti
Silmara Allegretti

1 April 2014 in Experimental Parasitology
Verified
Journal Article
Closed access
RORosimeire Nunes de Oliveira
Rosimeire Nunes de Oliveira
VRVera Lúcia Garcia Rehder
Vera Lúcia Garcia Rehder
AOAdriana Silva Santos Oliveira
Adriana Silva Santos Oliveira
VJVeronica de Lourdes Sierpe Jeraldo
Veronica de Lourdes Sierpe Jeraldo
ALArício Xavier Linhares
Arício Xavier Linhares
SASilmara Allegretti
Silmara Allegretti

1 March 2014 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
ASAna Luiza Ribeiro de Souza
Ana Luiza Ribeiro de Souza
TATatiana Andreani
Tatiana Andreani
RORosimeire Nunes de Oliveira
Rosimeire Nunes de Oliveira
CKCharlene Priscila Kiill
Charlene Priscila Kiill
FSFernanda Kolenyak dos Santos
Fernanda Kolenyak dos Santos
MGMaria Palmira Daflon Gremiao
Maria Palmira Daflon Gremiao

1 October 2010 in Veterinary Parasitology
Verified
Journal Article
Closed access
MAMarcos André
Marcos André
CAC.H. Adania
C.H. Adania
RTR.H.F. Teixeira
R.H.F. Teixeira
GVG.H. Vargas
G.H. Vargas
MFM. Falcade
M. Falcade
RMR.Z. Machado
R.Z. Machado